76 related articles for article (PubMed ID: 10881051)
1. Development of an operational substrate for ZapA, a metalloprotease secreted by the bacterium Proteus mirabilis.
Fernandes BL; Anéas MA; Juliano L; Palma MS; Lebrun I; Portaro FC
Braz J Med Biol Res; 2000 Jul; 33(7):765-70. PubMed ID: 10881051
[TBL] [Abstract][Full Text] [Related]
2. ZapA, a possible virulence factor from Proteus mirabilis exhibits broad protease substrate specificity.
Anéas MA; Portaro FC; Lebrun I; Juliano L; Palma MS; Fernandes BL
Braz J Med Biol Res; 2001 Nov; 34(11):1397-403. PubMed ID: 11668347
[TBL] [Abstract][Full Text] [Related]
3. Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides.
Belas R; Manos J; Suvanasuthi R
Infect Immun; 2004 Sep; 72(9):5159-67. PubMed ID: 15322010
[TBL] [Abstract][Full Text] [Related]
4. Characterization of kininogenase activity of an acidic proteinase isolated from human kidney.
Gomes RA; Juliano L; Chagas JR; Hial V
Can J Physiol Pharmacol; 1997 Jun; 75(6):757-61. PubMed ID: 9276160
[TBL] [Abstract][Full Text] [Related]
5. ZapA, the IgA-degrading metalloprotease of Proteus mirabilis, is a virulence factor expressed specifically in swarmer cells.
Walker KE; Moghaddame-Jafari S; Lockatell CV; Johnson D; Belas R
Mol Microbiol; 1999 May; 32(4):825-36. PubMed ID: 10361285
[TBL] [Abstract][Full Text] [Related]
6. Structural features that make oligopeptides susceptible substrates for hydrolysis by recombinant thimet oligopeptidase.
Camargo AC; Gomes MD; Reichl AP; Ferro ES; Jacchieri S; Hirata IY; Juliano L
Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):517-22. PubMed ID: 9182712
[TBL] [Abstract][Full Text] [Related]
7. A kinetic comparison of the homologous proteases astacin and meprin A.
Wolz RL
Arch Biochem Biophys; 1994 Apr; 310(1):144-51. PubMed ID: 8161197
[TBL] [Abstract][Full Text] [Related]
8. A novel autotransporter of uropathogenic Proteus mirabilis is both a cytotoxin and an agglutinin.
Alamuri P; Mobley HL
Mol Microbiol; 2008 May; 68(4):997-1017. PubMed ID: 18430084
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of a metalloprotease from Proteus mirabilis.
Wassif C; Cheek D; Belas R
J Bacteriol; 1995 Oct; 177(20):5790-8. PubMed ID: 7592325
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive inhibitor profiling of the Proteus mirabilis metalloprotease virulence factor ZapA (mirabilysin).
Carson L; Cathcart GR; Scott CJ; Hollenberg MD; Walker B; Ceri H; Gilmore BF
Biochimie; 2011 Oct; 93(10):1824-7. PubMed ID: 21762758
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments.
Del Nery E; Chagas JR; Juliano MA; Prado ES; Juliano L
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):233-8. PubMed ID: 7492318
[TBL] [Abstract][Full Text] [Related]
12. Specificity of S'1 and S'2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P'1 and P'2 positions in design of inhibitors.
Pimenta DC; Fogaça SE; Melo RL; Juliano L; Juliano MA
Biochem J; 2003 May; 371(Pt 3):1021-5. PubMed ID: 12578561
[TBL] [Abstract][Full Text] [Related]
13. Specific fluorogenic substrates for neprilysin (neutral endopeptidase, EC 3.4.24.11) which are highly resistant to serine- and metalloproteases.
Medeiros MA; França MS; Boileau G; Juliano L; Carvalho KM
Braz J Med Biol Res; 1997 Oct; 30(10):1157-62. PubMed ID: 9496431
[TBL] [Abstract][Full Text] [Related]
14. Substrate specificity of rabbit liver metalloendopeptidase and its new fluorogenic peptide substrates.
Kojima N; Kawabata S; Makinose Y; Nishino N; Iwanaga S
J Biochem; 1995 Oct; 118(4):855-61. PubMed ID: 8576104
[TBL] [Abstract][Full Text] [Related]
15. Differences in substrate and inhibitor sequence specificity of human, mouse and rat tissue kallikreins.
Fogaça SE; Melo RL; Pimenta DC; Hosoi K; Juliano L; Juliano MA
Biochem J; 2004 Jun; 380(Pt 3):775-81. PubMed ID: 15040788
[TBL] [Abstract][Full Text] [Related]
16. Substrate specificity of human cathepsin D using internally quenched fluorescent peptides derived from reactive site loop of kallistatin.
Pimenta DC; Oliveira A; Juliano MA; Juliano L
Biochim Biophys Acta; 2001 Jan; 1544(1-2):113-22. PubMed ID: 11341921
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the binding specificity of two bacterial metalloproteases, LasB of Pseudomonas aeruginosa and ZapA of Proteus mirabilis, using N-alpha mercaptoamide template-based inhibitor analogues.
Carson L; Cathcart GR; Ceri H; Walker B; Gilmore BF
Biochem Biophys Res Commun; 2012 Jun; 422(2):316-20. PubMed ID: 22575503
[TBL] [Abstract][Full Text] [Related]
18. The role of Tyr605 and Ala607 of thimet oligopeptidase and Tyr606 and Gly608 of neurolysin in substrate hydrolysis and inhibitor binding.
Machado MF; Rioli V; Dalio FM; Castro LM; Juliano MA; Tersariol IL; Ferro ES; Juliano L; Oliveira V
Biochem J; 2007 Jun; 404(2):279-88. PubMed ID: 17313369
[TBL] [Abstract][Full Text] [Related]
19. ZapA, a virulence factor in a rat model of Proteus mirabilis-induced acute and chronic prostatitis.
Phan V; Belas R; Gilmore BF; Ceri H
Infect Immun; 2008 Nov; 76(11):4859-64. PubMed ID: 18725420
[TBL] [Abstract][Full Text] [Related]
20. S3 to S3' subsite specificity of recombinant human cathepsin K and development of selective internally quenched fluorescent substrates.
Alves MF; Puzer L; Cotrin SS; Juliano MA; Juliano L; Brömme D; Carmona AK
Biochem J; 2003 Aug; 373(Pt 3):981-6. PubMed ID: 12733990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
